Search for Clinical Trial Results
Paraneoplastic Syndromes - 51 Studies Found
Status | Study |
Completed |
Study Name: A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS) Condition: Lambert Eaton Myasthenic Syndrome Date: 2011-06-17 Interventions:
|
No longer available |
Study Name: Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome Condition: Lambert-Eaton Myasthenic Syndrome Date: 2011-06-13 Interventions: Drug: 3,4 DAP Recommended maximum dosage: 20mg four times daily and if needed an additional 20 mg per da |
Completed |
Study Name: MC-5A for Chemotherapy Induced Peripheral Neuropathy Condition: Neuropathy, Paraneoplastic Date: 2010-12-09 Interventions:
|
Completed |
Study Name: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes Condition: Congenital Myasthenic Syndrome Date: 2010-09-15 Interventions: Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or |
Available |
Study Name: Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine Condition: Lambert-Eaton Myasthenic Syndrome Date: 2009-10-08 Interventions: Drug: 3,4 diaminopyridine 3,4 diaminopyridine up to 80 mg daily in divided doses |
Recruiting |
Study Name: The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes Condition: Paraneoplastic Syndromes Date: 2006-05-17 |
Active, not recruiting |
Study Name: Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China Condition: Anti-NMDA Receptor Enphalitis Date: 2015-09-23 |
Active, not recruiting |
Study Name: Ephedrine for the Treatment of Congenital Myasthenia Condition: Myasthenic Syndromes, Congenital Date: 2007-10-07 Interventions: Drug: Ephedrine |
Available |
Study Name: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome Condition:
Date: 2017-02-21 Interventions: Drug: 3,4-Diaminopyridine The investigator will prescribe an initial dose of 3,4 diaminopyridine (DAP) b |
Recruiting |
Study Name: Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS) Condition: Lambert-Eaton Myasthenic Syndrome Date: 2016-11-16 Interventions:
|